Company overview
NanoTemper Technologies provides high-quality biophysical characterization instruments for life sciences and pharma research, including Prometheus for stability analysis, Dianthus for affinity screening, and Monolith for molecular interactions. These tools support biologics formulation, developability assessments, protein expression optimization, and challenging targets like membrane proteins and IDPs. Solutions feature technologies such as nanoDSF, DLS, Spectral Shift, MST, and NSM for precise, automation-ready workflows.
Nanotemper Technologies is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include biophysical characterization, protein stability, binding affinity, nanodsf, mst technology.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://nanotempertech.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- biophysical characterization, protein stability, binding affinity, nanodsf, mst technology
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What biophysical characterization capabilities does NanoTemper offer?
- NanoTemper offers stability characterization (nanoDSF, DLS via Prometheus Panta), binding affinity measurements (Spectral Shift, MST via Dianthus and Monolith), protein expression optimization (Andromeda X), and advanced NSM (Dianthus α) for optical unfolding and slow kinetics.
- Which instruments are best for biologics developability and formulation?
- Prometheus Panta combines DLS for particle sizing, nanoDSF for thermal unfolding, and backreflection for aggregation, ideal for biologics formulation optimization, developability, and comparability studies.
- What geographies does NanoTemper serve and any regulatory info?
- NanoTemper operates globally with locations in South San Francisco (USA), Munich (Germany), and Gothenburg (Sweden via acquisition); instruments are designed for high-precision research in pharma/biopharma with no specific regulatory certifications detailed.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
